Enhancer Dysregulation
Enhancer Dysregulation is a pathogenic alteration in the activity of cis-regulatory DNA elements that control gene expression in a spatial, temporal, or cell-type-specific manner, characterized by aberrant enhancer activation or silencing that disrupts normal transcriptional programs in cancer.
37
Publications
2.2K
Citations
442
Authors
141
Institutions
Publications per year
2017–2026
25
Parents
37
KMT2D Deficiency Impairs Super-Enhancers to Confer a Glycolytic Vulnerability in Lung Cancer
Hunain Alam, Ming Tang, Mayinuer Maitituoheti et al. · Cancer Cell · 2020 · 244 citations · Full text
DiseaseEnhancer: a resource of human disease-associated enhancer catalog
Guanxiong Zhang, Jian Shi, Shiwei Zhu et al. · Nucleic Acids Research · 2017 · 95 citations · Full text
1–5 of 37
442
2
h-index
2
h-index
2
h-index
2
h-index
1
h-index
1–5 of 442
141

Princess Margaret Cancer Centre
Toronto, Canada
3 h-index
7 publications
234 citations

Sun Yat-sen University
Guangzhou, China
3 h-index
32 publications
573 citations

University of Toronto
Toronto, Canada
3 h-index
6 publications
138 citations
University Health Network
Toronto, Canada
3 h-index
6 publications
176 citations
National University Cancer Institute, Singapore
Singapore, Singapore
3 h-index
18 publications
983 citations
National University of Singapore
Singapore, Singapore
3 h-index
17 publications
880 citations
Duke-NUS Medical School
Singapore, Singapore
2 h-index
9 publications
184 citations
Kyushu University
Fukuoka, Japan
2 h-index
8 publications
452 citations
1–8 of 141
6 publications · 336 citations
6
h-index
3 publications · 294 citations
3
h-index
2 publications · 115 citations
2
h-index
2 publications · 201 citations
2
h-index
2 publications · 324 citations
2
h-index
1–5